These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22161274)

  • 21. Why does oestrogen-only hormone therapy have such a small impact on breast cancer risk? A hypothesis.
    Eden JA
    Gynecol Endocrinol; 2011 Mar; 27(3):170-5. PubMed ID: 20500114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
    Pérez-Palacios G; Santillán R; García-Becerra R; Borja-Cacho E; Larrea F; Damián-Matsumura P; González L; Lemus AE
    J Endocrinol; 2006 Sep; 190(3):805-18. PubMed ID: 17003281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
    Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
    Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
    Lu M; Miller KD; Gokmen-Polar Y; Jeng MH; Kinch MS
    Cancer Res; 2003 Jun; 63(12):3425-9. PubMed ID: 12810680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metals in human placenta: focus on the effects of cadmium on steroid hormones and leptin.
    Stasenko S; Bradford EM; Piasek M; Henson MC; Varnai VM; Jurasović J; Kusec V
    J Appl Toxicol; 2010 Apr; 30(3):242-53. PubMed ID: 19847775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
    Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
    J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action.
    Koohi MK; Ivell R; Walther N
    J Neuroendocrinol; 2005 Apr; 17(4):197-207. PubMed ID: 15842231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-selectivity: the mechanism of action of tibolone.
    Kloosterboer HJ
    Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of heavy metal toxicity on growth, symbiosis, seed yield and metal uptake in pea grown in metal amended soil.
    Wani PA; Khan MS; Zaidi A
    Bull Environ Contam Toxicol; 2008 Aug; 81(2):152-8. PubMed ID: 18368281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modern approaches to estrogen-independent growth of breast tumor].
    Krasil'nikov MA
    Vopr Onkol; 2004; 50(4):399-405. PubMed ID: 15605761
    [No Abstract]   [Full Text] [Related]  

  • 31. Cadmium and breast cancer - Current state and research gaps in the underlying mechanisms.
    Tarhonska K; Lesicka M; Janasik B; Roszak J; Reszka E; Braun M; Kołacińska-Wow A; Jabłońska E
    Toxicol Lett; 2022 May; 361():29-42. PubMed ID: 35331840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
    Matsumura A; Ghosh A; Pope GS; Darbre PD
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of micronuclei in eel (Anguilla anguilla L.) by heavy metals.
    Sanchez-Galan S; Linde AR; Ayllon F; Garcia-Vazquez E
    Ecotoxicol Environ Saf; 2001 Jun; 49(2):139-43. PubMed ID: 11386727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer.
    Bagatell R; Khan O; Paine-Murrieta G; Taylor CW; Akinaga S; Whitesell L
    Clin Cancer Res; 2001 Jul; 7(7):2076-84. PubMed ID: 11448926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen carcinogenesis in breast cancer.
    Germain D
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):473-84, vii. PubMed ID: 21889715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.
    Orso F; Cottone E; Hasleton MD; Ibbitt JC; Sismondi P; Hurst HC; De Bortoli M
    Biochem J; 2004 Jan; 377(Pt 2):429-38. PubMed ID: 14565844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of estrogenicity of major heavy metals.
    Choe SY; Kim SJ; Kim HG; Lee JH; Choi Y; Lee H; Kim Y
    Sci Total Environ; 2003 Aug; 312(1-3):15-21. PubMed ID: 12873394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotoxicology and Metalloestrogens: Possible Involvement in Breast Cancer.
    Wallace DR
    Toxics; 2015 Oct; 3(4):390-413. PubMed ID: 29051471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elastosis and oestrogen receptors in human breast cancer.
    Masters JR; Sangster K; Hawkins RA; Shivas AA
    Br J Cancer; 1976 Mar; 33(3):342-3. PubMed ID: 178332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.